Living Donor Kidney Transplant: Surgery, Recovery, and Outcomes

A living donor kidney transplant is the gold standard treatment for end-stage renal disease, offering recipients a faster path to a functioning kidney, better long-term outcomes, and a surgery that can be planned at a time that works for the entire care team. Unlike the unpredictable wait associated with a deceased-donor transplant — often measured in years — a living donor transplant can be scheduled once evaluation is complete, dramatically improving quality of life and reducing the risks that accumulate during dialysis. In my practice at Centro Médico González in Mexicali, Baja California, I have performed more than 2,000 procedures over 20 years, and living donor kidney transplants remain one of the most rewarding operations in transplant surgery — for the surgeon, the donor, and most of all, the recipient.

What Is a Living Donor Kidney Transplant?

A living donor kidney transplant is a surgical procedure in which a healthy, living person voluntarily donates one of their two kidneys to a patient with kidney failure. The human body functions normally with a single kidney; the remaining kidney adapts over time to filter blood at a rate close to what two kidneys achieve together.

Why Living Donors Are Preferred Over Deceased Donors

Living donor transplants consistently outperform deceased-donor transplants across every major metric in transplant medicine:

Graft survival: Living donor kidneys survive an average of 15–20 years, compared with 10–15 years for deceased-donor kidneys.
Immediate function: Living donor kidneys begin producing urine on the operating table in the vast majority of cases. Delayed graft function — a common complication with deceased-donor organs — is significantly less frequent.
Scheduled surgery: The transplant is planned in advance, allowing both donor and recipient to be in optimal health before the procedure.
Cold ischemia time: The interval between kidney removal and implantation is measured in minutes rather than hours, preserving organ quality.
Waiting list elimination: Patients with a willing, compatible living donor bypass the national transplant waiting list entirely.

Who Can Be a Living Donor?

A living kidney donor is typically a blood relative (parent, sibling, child) or an emotionally related person (spouse, close friend). Thanks to paired kidney exchange programs and advanced immunosuppression protocols, biological compatibility is less restrictive than it once was. Full compatibility criteria and the evaluation process are covered in my dedicated post on kidney donor requirements and compatibility.

The Living Donor Evaluation Process

Before any surgery takes place, both the potential donor and the recipient undergo thorough independent medical evaluations. This process protects the donor's long-term health and ensures the best possible outcome for the recipient.

Donor Medical Evaluation

The donor evaluation is comprehensive and typically completed over 2–4 weeks of outpatient appointments. It includes:

Laboratory testing: - Complete blood count, comprehensive metabolic panel - Blood type and tissue typing (HLA matching) - Crossmatch testing to detect preformed antibodies - 24-hour urine creatinine clearance (measuring baseline kidney function) - Urinalysis and urine culture - Infectious disease screening: HIV, hepatitis B and C, CMV, EBV

Imaging studies: - CT angiography of the kidneys and renal vessels — this is the most important imaging study, showing kidney size, anatomy, and the vascular supply to each kidney - Chest X-ray and ECG

Specialist consultations: - Transplant nephrologist (independent from the recipient's care team) - Transplant surgeon - Social worker and/or psychologist — to verify the donation is truly voluntary and free of coercion - Anesthesiologist pre-operative assessment

Recipient Pre-Transplant Evaluation

The recipient also undergoes a pre-transplant workup to confirm surgical readiness:

Current kidney function (eGFR, creatinine, BUN)
Cardiac evaluation — stress testing or echocardiogram in patients with diabetes or cardiovascular risk
Immunological panel reactive antibody (PRA) testing to assess sensitization
Cancer screening appropriate for age
Dental clearance (dental infections can complicate immunosuppression)
Vaccination update (live vaccines cannot be given after transplant)

The Donor Surgery: Laparoscopic Nephrectomy

The donor kidney removal — called a donor nephrectomy — is performed using a minimally invasive laparoscopic technique in the vast majority of cases. This approach has transformed living donation, making it safer, less painful, and requiring significantly less recovery time compared to the open surgical technique used in previous decades.

How Laparoscopic Donor Nephrectomy Works

Under general anesthesia, the donor lies on their side. The surgeon makes 3–4 small incisions (each less than 1 cm) plus one slightly larger incision (4–7 cm) for kidney extraction. A laparoscope — a slender camera — is inserted through one port, and specialized instruments through the others.

The steps are:

Mobilization: The colon is gently moved to expose the kidney.
Vessel dissection: The renal artery and renal vein are carefully isolated and dissected free from surrounding tissue.
Ureter identification: The ureter (the tube draining urine from the kidney to the bladder) is traced downward and divided at an appropriate length.
Vascular control: Surgical clips are applied to the renal artery and vein, which are then divided, freeing the kidney completely.
Extraction: The kidney is placed in a retrieval bag and brought out through the extraction incision within seconds.

Total operative time is typically 60 to 90 minutes in experienced hands. In my practice, I have refined this technique over hundreds of procedures to minimize operative time, blood loss, and the risk of conversion to open surgery.

Left vs. Right Kidney: Which Is Donated?

The surgical team evaluates CT angiography findings to determine which kidney to remove from the donor. In most cases, the left kidney is preferred because its renal vein is longer, making the implantation into the recipient technically easier. The right kidney is used when anatomical factors — such as superior function, fewer accessory vessels, or cyst presence — make it the better choice for the recipient.

Risks and Safety of Donor Nephrectomy

Living kidney donation is safe for carefully selected donors, but it is not without risk. Donors should have an honest conversation with their surgical team about:

Surgical complications: Bleeding, infection, hernia at the incision site, and injury to adjacent structures (bowel, spleen, liver) — each occurring in less than 2% of laparoscopic cases.
Conversion to open surgery: Required in fewer than 1% of laparoscopic procedures.
Long-term kidney function: Donors retain approximately 70–75% of their pre-donation GFR. Most donors live normal, healthy lives with one kidney and face no significant increase in dialysis or kidney failure risk compared to the general population when properly selected.
Blood pressure: Some studies show a modest increase in blood pressure decades after donation; donors benefit from annual blood pressure monitoring.

The Recipient Surgery: Kidney Implantation

While the donor is in one operating room, the recipient is simultaneously prepared in an adjacent room. The two procedures are coordinated precisely to minimize cold ischemia time — the time the donated kidney spends outside a human body.

Surgical Technique for the Recipient

The recipient surgery takes 3 to 4 hours under general anesthesia. Key steps include:

Incision: A curved incision is made in the lower abdomen (right or left iliac fossa). The patient's own diseased kidneys are left in place in most cases — they atrophy naturally over time.
Vascular anastomosis: The donor renal artery is connected to the recipient's external iliac artery, and the donor renal vein to the external iliac vein. These connections restore blood flow to the new kidney.
Ureteral anastomosis: The donor ureter is connected to the recipient's bladder (ureteroneocystostomy), allowing urine to drain normally.
Reperfusion: Blood flow is restored to the kidney. In a well-matched living donor transplant, the kidney typically begins producing urine within minutes — a moment that never fails to be remarkable in the operating room.

A double-J ureteral stent is placed internally at the time of surgery to protect the ureteral connection; it is removed 4–6 weeks later in an outpatient procedure.

Recovery: What to Expect After a Living Donor Kidney Transplant

Recovery timelines differ between the donor and the recipient.

Donor Recovery Timeline

The donor's recovery after laparoscopic nephrectomy is generally straightforward:

Hospital stay: 1–3 days
Pain management: Oral pain medication is usually sufficient; the laparoscopic approach produces significantly less pain than open surgery
Return to light activity: 1–2 weeks after discharge
Return to work (desk job): 2–4 weeks
Return to physical work or exercise: 4–6 weeks
Long-term follow-up: Blood pressure, creatinine, and urinalysis at 6 months, 1 year, and annually thereafter

Recipient Recovery Timeline

The recipient's recovery is more complex because of the immunosuppression required to prevent rejection:

Hospital stay: 5–10 days, depending on how quickly the new kidney establishes function and whether complications arise
Foley catheter: Removed 3–5 days post-surgery once the ureter heals
Discharge criteria: Stable creatinine trending downward, adequate urine output, oral medication tolerance, and ability to self-monitor
Return to light activity: 4–6 weeks
Return to work: 6–12 weeks, depending on the physical demands of the job
Driving: Typically 4–6 weeks post-surgery

Immunosuppression After Kidney Transplant

Preventing rejection is the central ongoing challenge of kidney transplantation. The immune system recognizes the transplanted kidney as foreign and will attack it without lifelong immunosuppressive medication.

Standard Immunosuppression Protocol

I follow evidence-based triple immunosuppression therapy, individualized to each patient's risk profile:

Calcineurin inhibitor: Tacrolimus is the cornerstone of modern kidney transplant immunosuppression. Target trough levels are typically 8–12 ng/mL in the first six months, tapering to 4–8 ng/mL thereafter.
Antimetabolite: Mycophenolate mofetil (MMF) inhibits T-cell and B-cell proliferation, working synergistically with tacrolimus.
Corticosteroids: Prednisone is used at induction and tapered to a low maintenance dose; some patients are weaned off steroids entirely after the first year under close monitoring.

Monitoring for Rejection

Recipients are monitored closely for acute rejection, particularly in the first year:

Weekly blood tests for the first month (creatinine, tacrolimus levels, CBC)
Monthly blood tests through months 2–6
Quarterly blood tests after the first year (assuming stable function)

Any unexpected rise in creatinine — even a modest 20–25% increase above baseline — prompts investigation. A kidney biopsy remains the gold standard for diagnosing rejection and guiding treatment.

Long-Term Outcomes and Quality of Life

Living donor kidney transplant recipients can expect meaningful improvements across all quality-of-life measures:

Dialysis independence: Freedom from dialysis is often described by patients as the most transformative change — no more 3–4 hour sessions three times per week.
Energy and exercise capacity: Most recipients report dramatically improved energy within weeks of transplantation as anemia resolves and uremic toxins clear.
Diet liberalization: Dietary restrictions (fluid, potassium, phosphorus) are significantly relaxed after successful transplantation.
Life expectancy: A functioning kidney transplant adds an average of 10–15 years of life compared to remaining on dialysis, with living donor recipients faring best of all.

Post-Transplant Complications to Monitor

Long-term vigilance is essential. Recipients face elevated risks of:

Infection: Immunosuppression blunts the immune response, increasing susceptibility to bacterial, viral (CMV, BK virus), and fungal infections
Malignancy: Skin cancers and lymphomas are more common in transplant recipients; annual dermatology visits are recommended
Cardiovascular disease: Hypertension and dyslipidemia are common side effects of tacrolimus and corticosteroids
Chronic allograft nephropathy: Gradual loss of function over time, the leading cause of late graft failure

Why Choose Centro Médico González in Mexicali?

For patients from the United States — particularly California, Arizona, and Nevada — Mexicali offers a uniquely practical combination of world-class surgical expertise and geographic accessibility.

Geographic Advantage

Centro Médico González is located just 5 minutes from the Calexico East border crossing, making it reachable in a single day from San Diego, Los Angeles, Phoenix, or Las Vegas without air travel. Families can stay on the U.S. side and cross daily to visit hospitalized patients.

Dr. César Eduardo González Muñoz

As your surgeon, I bring 20+ years of specialized experience in transplant and hepatobiliary surgery, with more than 2,000 procedures performed. I hold certification from the Consejo Mexicano de Cirugía General and carry COFEPRIS license 21020353A00412. My practice at Blvd. Francisco L. Montejano 1188, Fracc. Fovissste, Mexicali, B.C. is fully equipped for the complete living donor kidney transplant process — from pre-operative evaluation through long-term follow-up.

Coordinated Care

Living donor transplants require seamless coordination between the donor surgical team and the recipient team. In my practice, both surgeries are performed in adjacent operating rooms with the same anesthesia team and nursing staff, minimizing cold ischemia time and ensuring consistent standards of care throughout.

How to Get Started: The Living Donor Pathway

If you or a family member is considering a living donor kidney transplant, the process begins with a consultation. During our first meeting, I review the recipient's current kidney function, dialysis history, overall health status, and preliminary information about the potential donor.

There are 3 main steps to getting started:

Recipient consultation: Review of medical records, labs, and imaging to confirm transplant candidacy.
Donor evaluation: Independent medical, psychological, and social evaluation of the potential donor.
Coordination and scheduling: Once both donor and recipient are cleared, surgery is scheduled at a mutually convenient time.

You can reach our clinic at +52-686-338-3848 or visit us at Centro Médico González, Blvd. Francisco L. Montejano 1188, Fracc. Fovissste, 21020 Mexicali, B.C., Mexico.

Frequently Asked Questions About Living Donor Kidney Transplant

Can a living donor be someone who is not a blood relative? Yes. Emotionally related donors — spouses, close friends, coworkers — are accepted at most transplant centers, including mine. The key requirements are good health, voluntariness, and adequate compatibility. In paired exchange programs, even incompatible donor-recipient pairs can participate by swapping with another compatible pair.

How long does the donor evaluation take? In most cases, the evaluation process — including all labs, imaging, and consultations — takes 2 to 4 weeks of outpatient appointments. Urgent cases can sometimes be expedited.

Will the donor need to take any medications long-term? No. Unlike the recipient, the donor does not take any immunosuppressive medication. The vast majority of living kidney donors require no long-term medications directly related to their donation, though annual monitoring of blood pressure and kidney function is recommended.

What happens if the donor's remaining kidney fails years later? In carefully selected donors, the risk of kidney failure is very low — comparable to that of healthy individuals who never donated. If a donor does develop kidney failure decades later, they receive priority on the deceased-donor transplant waiting list in Mexico and in many other countries.

How is cold ischemia time minimized in a living donor transplant? Both surgeries — donor nephrectomy and recipient implantation — are performed simultaneously in coordinated operating rooms. The moment the donor kidney is removed, it is immediately flushed with cold preservation solution and handed to the recipient surgical team, who are already prepared to implant it. Total cold ischemia time in our practice is typically under 60 minutes.

Is laparoscopic nephrectomy always possible for the donor? In more than 99% of cases, yes. Conversion to open surgery is required only in rare situations: significant intraoperative bleeding, unexpected anatomical complexity, or technical equipment issues. Pre-operative CT angiography allows us to plan the surgical approach in detail and anticipate challenging anatomy.

Can a patient on peritoneal dialysis receive a living donor transplant? Yes. Both hemodialysis and peritoneal dialysis patients are candidates for living donor transplants. Notably, in some centers — including mine — a pre-emptive transplant (before dialysis begins, when eGFR falls below 15–20 mL/min/1.73m²) is offered to patients with a willing living donor, which carries the best outcomes of all.

What immunosuppression medications will the recipient take long-term? Most recipients remain on tacrolimus and mycophenolate mofetil indefinitely. Corticosteroids may be tapered and discontinued after the first year in low-risk patients. Medication doses are adjusted based on regular monitoring of drug levels, kidney function, and side effects.

How do I know if my potential donor is compatible? Blood type compatibility is the first filter. Beyond that, HLA tissue typing and crossmatch testing determine immunological compatibility. My team coordinates all compatibility testing as part of the donor evaluation; results typically take 1–2 weeks.

Can older patients (65+) receive a living donor kidney transplant? Age alone is not a contraindication to kidney transplantation. I evaluate older patients on a case-by-case basis, with particular attention to cardiovascular fitness and the absence of active malignancy. Many patients in their 60s and 70s do extremely well after transplantation, particularly when receiving a living donor organ that begins functioning immediately.

Start Your Journey Toward Kidney Transplant Freedom

A living donor kidney transplant can restore years of quality life — for both the recipient freed from dialysis and the donor who gives the gift of kidney function. If you or someone you love is facing end-stage renal disease and a willing donor is available, I encourage you to contact my clinic to discuss whether a living donor transplant is the right path forward.

Centro Médico González Blvd. Francisco L. Montejano 1188, Fracc. Fovissste, 21020 Mexicali, B.C., Mexico 📞 +52-686-338-3848 *5 minutes from the Calexico, CA border crossing*